Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 221

Results For "Eni"

2822 News Found

One-dose HPV vaccine offers solid protection against cervical cancer
News | April 12, 2022

One-dose HPV vaccine offers solid protection against cervical cancer

This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls


Carestream installs DRX Compass at Gati Diagnostic Centre
Medical Device | April 12, 2022

Carestream installs DRX Compass at Gati Diagnostic Centre

The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers


Aleor receives USFDA approval for Lidocaine and Prilocaine Cream
Drug Approval | April 12, 2022

Aleor receives USFDA approval for Lidocaine and Prilocaine Cream

Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


Thermo Fisher Scientific deploys cryo-transmission electron microscope at CCMB, Hyderabad
Medical Device | April 12, 2022

Thermo Fisher Scientific deploys cryo-transmission electron microscope at CCMB, Hyderabad

It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research


Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States


Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
Biotech | April 11, 2022

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology


CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
Biotech | April 11, 2022

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid

These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection


BMSF names diversity in clinical trials training program after Robert A Winn
Sustainability | April 11, 2022

BMSF names diversity in clinical trials training program after Robert A Winn

The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027


Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Biotech | April 11, 2022

Moderna kickstarts Phase 1/2 study for influenza vaccine candidate

Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle